• SMYD2 Inhibition Attenuates Renal Fibrosis in Cisplatin-Indu

  2026-06-30

  This study demonstrates that pharmacological inhibition of SMYD2, notably with AZ505, protects against cisplatin-induced renal fibrosis and inflammation. By elucidating SMYD2's role in epithelial-mesenchymal transition and fibrotic signaling, the research advances our understanding of epigenetic regulation in chronic kidney disease and highlights new therapeutic targets.

• JC-1 Mitochondrial Membrane Potential Assay Kit: Applied Ins

  2026-06-30

  The JC-1 Mitochondrial Membrane Potential Assay Kit by APExBIO enables sensitive, ratiometric detection of mitochondrial health and apoptosis, optimized for translational research needs. This guide delivers actionable workflow tips, troubleshooting strategies, and evidence-backed enhancements to maximize assay reliability in cancer, neurodegeneration, and drug screening studies.

• Mianserin HCl: 5-HT2 Receptor Antagonist in Research Workflo

  2026-06-29

  Mianserin HCl is a tetracyclic 5-HT2 receptor antagonist with robust evidence for use in antidepressant research and emerging antipathogenic applications. This article details its mechanism, protocol parameters, and critical differences from other antidepressant compounds.

• Super-Enhancer RNA Drives NPC Metastasis via NDRG1 Activatio

  2026-06-29

  This study elucidates how exposure to chemical carcinogen DNP promotes nasopharyngeal carcinoma (NPC) metastasis by upregulating a specific super-enhancer RNA (seRNA-NPCm). Through multi-omics and functional assays, the authors reveal that seRNA-NPCm interacts with the NPM1/c-Myc complex to enhance NDRG1 transcription, linking epigenetic regulation to aggressive tumor behavior.

• NU7441 (KU-57788): Enhancing DNA Repair and Oncology Researc

  2026-06-28

  NU7441 (KU-57788) unlocks precision in DNA repair and oncology workflows by selectively inhibiting DNA-PK, enabling robust cell cycle modulation and sensitization to DNA-damaging agents. With proven potency and reproducibility, this APExBIO tool streamlines complex experimental designs and troubleshooting.

• (S)-Mephenytoin: CYP2C19 Substrate for Human Drug Metabolism

  2026-06-27

  (S)-Mephenytoin is a validated CYP2C19 substrate widely used in cytochrome P450 metabolism and pharmacokinetic studies. Its mechanistic specificity and well-documented parameters make it a benchmark tool for human-relevant in vitro drug metabolism research.

• Indomethacin in Inflammation Research: Protocols and Innovat

  2026-06-26

  Indomethacin’s dual action as a Cox-1 selective inhibitor and PPARγ agonist empowers cutting-edge inflammation and lipid metabolism studies. This article details advanced workflows, troubleshooting guidance, and practical insights for leveraging Indomethacin from APExBIO in membrane signaling and anti-inflammatory drug research.

• hiPSC-Derived Intestinal Organoids for CYP2C19 Substrate Stu

  2026-06-26

  This study introduces a streamlined protocol for generating human induced pluripotent stem cell-derived intestinal organoids (hiPSC-IOs) suitable for pharmacokinetic research. By enabling long-term expansion and functional differentiation of enterocytes that express drug-metabolizing enzymes, the model advances in vitro evaluation of CYP2C19 substrates such as (S)-Mephenytoin, addressing key limitations of traditional systems.

• Phosbind Acrylamide: Precision Phosphate-Binding Reagent for

  2026-06-25

  Phosbind Acrylamide is a specialized phosphate-binding reagent enabling precise, antibody-free protein phosphorylation analysis via SDS-PAGE. It distinguishes phosphorylated from non-phosphorylated proteins through MnCl2-mediated binding, supporting sensitive detection and workflow efficiency. The reagent is optimal for targets in the 30–130 kDa range and operates at neutral physiological pH.

• (S)-Mephenytoin as a Precision CYP2C19 Substrate for In Vitr

  2026-06-25

  (S)-Mephenytoin enables precise measurement of CYP2C19-mediated drug metabolism in advanced in vitro models, including human intestinal organoids. This article bridges protocol innovation, troubleshooting, and benchmarking insights, empowering researchers to elevate pharmacokinetic studies using APExBIO's high-purity substrate.

• Bacillus Strains and Media Shape γ-Glutamyl Peptide Synthesi

  2026-06-24

  This study rigorously evaluates how different Bacillus strains and growth media control the synthesis of γ-glutamyl peptides, including γ-Glu-Cys, with implications for targeted peptide production and food flavor enhancement. The findings establish that medium composition exerts a stronger influence than strain selection, guiding future research in glutathione metabolism and kokumi-active peptide engineering.

• (+)-Bicuculline: Technical Guidance for GABAA Antagonist Use

  2026-06-23

  (+)-Bicuculline is a classical GABAA receptor antagonist for dissecting inhibitory neurotransmission and synaptic NMDA receptor signaling in neuroscience research. It is not suitable for diagnostic or therapeutic use, and reliable results require strict adherence to solubility and storage protocols.

• AZ505: A SMYD2 Inhibitor Transforming Epigenetic Disease Res

  2026-06-23

  AZ505, a potent and selective SMYD2 inhibitor from APExBIO, is reshaping translational epigenetic research with its high specificity and robust performance in cellular and disease models. Its use in renal fibrosis and cancer workflows streamlines mechanistic assays and opens new directions for targeted intervention.

• Liproxstatin-1 in Ferroptosis Research: Mechanistic Depth &

  2026-06-22

  Explore how Liproxstatin-1, a potent ferroptosis inhibitor, advances cell death research by revealing membrane-level regulatory mechanisms and translational potential. This article delivers a unique, in-depth analysis of Liproxstatin-1’s assay applications and mechanistic insights.

• 2,7-Dichlorodihydrofluorescein Diacetate: ROS Assay Workflow

  2026-06-22

  2,7-Dichlorodihydrofluorescein diacetate (DCFH-DA) enables sensitive, cell-permeable detection of intracellular ROS, unlocking quantitative studies in oxidative stress, mitochondrial dysfunction, and inflammation. This guide translates state-of-the-art research and troubleshooting into actionable protocols for fluorescence microscopy, flow cytometry, and plate-based assays.

462 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page